SCHEMBL5225686

SCHEMBL5225686

C/C=C\c1cc(C(=O)OC)cc(N2CCCC2=O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
ALDH1A1 P00352 6/20 0.45
HPGD P15428 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
TDP1 Q9NUW8 1/20 0.44
POLB P06746 1/20 0.42
GAA P10253 2/20 0.42
GFER P55789 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
MAPT P10636 2/20 0.41
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5225688 1.00 KMT2A (0.46) KMT2AMEN1ALDH1A1HPGDCYP1A2
SCHEMBL5223732 0.87 ALDH1A1 (0.51) KMT2AMEN1ALDH1A1HPGDCYP1A2
SCHEMBL5223738 0.87 ALDH1A1 (0.51) KMT2AMEN1ALDH1A1HPGDCYP1A2
SCHEMBL28758828 0.86 ALDH1A1 (0.52) KMT2AMEN1ALDH1A1HPGDCYP1A2
SCHEMBL475775 0.85 MEN1 (0.56) KMT2AMEN1ALDH1A1HPGDCYP1A2
SCHEMBL5219444 0.85 MEN1 (0.56) KMT2AMEN1ALDH1A1HPGDCYP1A2
SCHEMBL5218127 0.85 KMT2A (0.46) KMT2AMEN1ALDH1A1HPGDCYP1A2
SCHEMBL5216908 0.83 ALDH1A1 (0.39) KMT2AMEN1ALDH1A1HPGDCYP1A2
SCHEMBL5216902 0.83 ALDH1A1 (0.39) KMT2AMEN1ALDH1A1HPGDCYP1A2
SCHEMBL5217876 0.82 MEN1 (0.50) KMT2AMEN1ALDH1A1HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed